Table 3.

Age-specific mortality rates of lymphoma and myeloma, stratified by residence, 2017 (1/10⁵)

Age group	All areas			Urban areas			Rural areas
	Both	Male	Female	Both	Male	Female	Both	Male	Female
0–1	0.34	0.56	0.08	0.00	0.00	0.00	0.46	0.74	0.11
1–4	0.26	0.30	0.20	0.17	0.19	0.15	0.29	0.3	0.22
5–9	0.33	0.41	0.24	0.32	0.40	0.22	0.34	0.42	0.25
10–14	0.37	0.44	0.30	0.37	0.51	0.20	0.38	0.41	0.34
15–19	0.45	0.55	0.33	0.40	0.53	0.26	0.47	0.57	0.37
20–24	0.34	0.49	0.18	0.21	0.26	0.16	0.41	0.62	0.19
25–29	0.49	0.65	0.34	0.46	0.60	0.32	0.51	0.67	0.35
30–34	0.86	1.02	0.70	0.86	1.12	0.60	0.86	0.96	0.76
35–39	0.89	1.17	0.59	0.79	0.93	0.65	0.95	1.32	0.56
40–44	1.26	1.55	0.96	1.13	1.13	1.13	1.33	1.77	0.87
45–49	1.90	2.22	1.59	1.80	1.91	1.70	1.96	2.38	1.54
50–54	5.31	6.53	4.03	5.29	6.82	3.66	5.32	6.38	4.22
55–59	4.33	5.57	3.07	4.67	6.13	3.20	4.14	5.27	3.00
60–64	10.27	13.06	7.41	12.24	15.30	9.12	9.35	12.01	6.61
65–69	14.85	18.90	10.83	17.31	21.82	12.86	13.73	17.57	9.91
70–74	17.28	21.86	12.85	20.07	24.42	16.06	15.86	20.61	11.14
75–79	18.67	23.61	14.29	23.94	31.02	17.77	15.89	19.75	12.43
80–84	25.23	32.59	19.35	37.29	44.39	31.39	19.45	26.73	13.76
85+	26.69	37.90	19.70	43.76	60.33	32.72	18.64	26.66	13.81